SHANGHAI, Feb 26 (Reuters) - Jiuyuan Genetic Biopharmaceutical has applied for approval to sell its experimental biosimilar version of Novo Nordisk's blockbuster weight-loss drug Wegovy in China, the ...
Predictable reimbursement is a primary operational determinant of biosimilar longevity in practices, frequently outweighing ...
In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.
Under the terms of a settlement and license agreement with Regeneron, Samsung Bioepis will be able to launch Opuviz in the ...
Aprogen spikes on biosimilar progress as Korea weighs risks from capital cut Shares hit limit-up on biosimilar shortcut hopes ...
The global biosimilar contract manufacturing market size was valued at USD 9.22 billion in 2025 and is predicted to hit ...
Zydus Lifesciences Limited, ("Zydus"), an innovation-led life-sciences company with an international presence with ...
The report reveals opportunities in identifying market leaders, potential acquisitions, and companies with strong sales growth in the generic and biosimilar pharmaceuticals sector. It offers insights ...
In 2025, we introduced a new collaborative Biosimilar Taskforce to address this potentially transformative area. The taskforce coordinates activity across the system , optimise biosimilar uptake and ...
The FDA approves biosimilar chemo infection risk treatment Filkri for cancer patients, expanding granulocyte colony-stimulating factor options.
Dr. Reddy’s Laboratories (RDY) stock is in focus as the FDA agrees to review its biosimilar targeting Bristol Myers' (BMY) arthritis drug, Orencia. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results